Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
well as collaboration with clinicians for human tissue studies. Profile Essential You have an international PhD in physiology, neuroscience, biomedical sciences, or related fields. You are an expert in molecular biology
-
tissue studies. Essential You have an international PhD in physiology, neuroscience, biomedical sciences, or related fields. You are an expert in molecular biology and/or electrophysiology. You are eager
-
presentations, and potential valorization or IP development. Job requirements A PhD in data science, applied physics, chemistry, materials science, bioengineering, or a related field, with a strong focus on data
-
should have a strong background in a quantitative discipline and an interest in neurodegenerative diseases. Essential: You obtained a PhD in Computational Neuroscience, Bioinformatics, Computer Science
-
should have a strong background in a quantitative discipline and an interest in neurodegenerative diseases. Essential: You obtained a PhD in Computational Neuroscience, Bioinformatics, Computer Science
-
developmental biology, cell biology and evolutionary biology. We like to implement novel omics technologies such as single cell approaches and chemical biology to help us answering our biological questions
-
and the IT support team. What we are looking for You hold a PhD in bioinformatics (ideally obtained after the 1st of Oct 2022). You are an experienced user of Python, R and Nextflow. You have experience
-
PhD is within relevant area for the MINDFUL project (neurodegenerative diseases, organoid technology using guided and unguided differentiation, experience with microglia, AD and MS). You should be also
-
interest in neurobiology and/or evolutionary biology, with a strong background in bioinformatics. PhD in Bioinformatics, Engineering, Computer Science, Physics, Bio-engineering, or Life Sciences
-
? You have a strong background (PhD) in single cell/spatial omics technologies and implementation. Having successfully applied state-of-the-art genetic engineering technologies (such as CRISPR/Cas9